Silly Nice Welcomes Schedule III-But Says Justice Reform Must Follow
A recent executive order has moved cannabis from Schedule I to Schedule III, recognising its medical benefits. The change also paves the way for broader research into its uses. One New York-based brand, Silly Nice, has welcomed the shift while pushing for deeper reforms.
The veteran-owned company, known for its premium small-batch flower and concentrates, is among the fastest-growing craft cannabis names in the state’s adult-use market. Its products are now stocked in over 125 licensed dispensaries across New York.
Silly Nice has long focused on healing, equity, and high-quality cannabis produced with integrity. The brand’s stance remains non-partisan, arguing that cannabis reform should move beyond political divisions. While celebrating the rescheduling, the company stresses that systemic corrections are still needed for those harmed by past policies.
The order itself aims to create clearer rules for full-spectrum hemp-derived cannabinoid products. Silly Nice is now watching how the Schedule III reclassification will affect key issues like 280E tax reform, banking restrictions, and interstate commerce. These changes could ease financial burdens on businesses and open new opportunities for growth.
Beyond regulatory shifts, the brand is calling for automatic expungement of non-violent cannabis offences. It also demands the release of incarcerated individuals, fairer access to business licences, and stronger protections for small operators. With potential multistate expansion on the horizon, Silly Nice is preparing for new partnerships while continuing its advocacy for social equity in the industry.
The rescheduling of cannabis marks a significant step toward wider acceptance and research. For Silly Nice, the focus now turns to ensuring the reforms translate into real-world benefits for communities and small businesses. The brand’s push for expungement, fair licensing, and financial reform will shape its next moves in an evolving market.
